HANNAH BRENDAN (Chief Business Officer) purchased 15.1% of their position (38.92K shares) of QUINCE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $24.2K — a significant purchase. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 8/21/2024ACC: 0001415889-24-021869
Officer· Chief Business Officer
Since May 2022
+38.92K
Net shares
Net buyer
$24.2K
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
38.92K acquired
Non-Derivative Transactions6
Common Stock
Direct
Shares
+2.15K
Price / share
$0.58
Trade value
$1.25K
% of position
0.8%
8/19/2024
257.62K→259.77K
Common Stock
Direct
Shares
+2.50K
Price / share
$0.61
Trade value
$1.52K
% of position
1.0%
8/20/2024
259.77K→262.27K
Common Stock
Direct
Shares
+3.42K
Price / share
$0.60
Trade value
$2.05K
% of position
1.3%
8/20/2024
262.27K→265.69K
Common Stock
Direct
Shares
+2.28K
Price / share
$0.61
Trade value
$1.39K
% of position
0.9%
8/21/2024
265.69K→267.98K
Common Stock
Direct
Shares
+5K
Price / share
$0.62
Trade value
$3.10K
% of position
1.9%
8/21/2024
267.98K→272.98K
Common Stock
Direct
Shares
+23.57K
Price / share
$0.63
Trade value
$14.85K
% of position
8.6%
8/21/2024
272.98K→296.54K
Total
Net shares
+38.92K
Net value
$24.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/19/2024 | P · Purchase | +2.15K | $0.58 | $1.25K | 0.8% | 257.62K | 259.77K |
| Common Stock Direct | 8/20/2024 | P · Purchase | +2.50K | $0.61 | $1.52K | 1.0% | 259.77K | 262.27K |
| Common Stock Direct | 8/20/2024 | P · Purchase | +3.42K | $0.60 | $2.05K | 1.3% | 262.27K | 265.69K |
| Common Stock Direct | 8/21/2024 | P · Purchase | +2.28K | $0.61 | $1.39K | 0.9% | 265.69K | 267.98K |
| Common Stock Direct | 8/21/2024 | P · Purchase | +5K | $0.62 | $3.10K | 1.9% | 267.98K | 272.98K |
| Common Stock Direct | 8/21/2024 | P · Purchase | +23.57K | $0.63 | $14.85K | 8.6% | 272.98K | 296.54K |
| Total | +38.92K | $24.17K | ||||||
Derivative Transactions0
No derivative transactions reported